These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36730977)
21. Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1. Beres SJ; Avery RA Semin Pediatr Neurol; 2017 May; 24(2):92-99. PubMed ID: 28941532 [TBL] [Abstract][Full Text] [Related]
22. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1. de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320 [TBL] [Abstract][Full Text] [Related]
23. Ophthalmological assessment of children with neurofibromatosis type 1. Cassiman C; Legius E; Spileers W; Casteels I Eur J Pediatr; 2013 Oct; 172(10):1327-33. PubMed ID: 23708214 [TBL] [Abstract][Full Text] [Related]
24. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Listernick R; Ferner RE; Liu GT; Gutmann DH Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups. Tosun M; Güngör M; Uslu H; Anık Y Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715 [TBL] [Abstract][Full Text] [Related]
26. Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas? Schindera C; Wingeier K; Goeggel Simonetti B; Diepold M; Nauer CB; Fleischhauer J; Steinlin M Childs Nerv Syst; 2011 Dec; 27(12):2107-11. PubMed ID: 21822956 [TBL] [Abstract][Full Text] [Related]
27. Complications and visual outcomes following surgical resection of pediatric optic pathway/hypothalamic gliomas: a systematic review and meta-analysis. Albalkhi I; Shafqat A; Bin-Alamer O; Mallela AN; Gersey ZC; Fernandes Cabral D; Sabbagh AJ; Hadjipanayis CG; González-Martínez JA; Friedlander RM; Abou-Al-Shaar H Childs Nerv Syst; 2024 Jul; 40(7):2033-2042. PubMed ID: 38649470 [TBL] [Abstract][Full Text] [Related]
28. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362 [TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children]. Florent C; Beylerian M; Mairot K; Dambricourt L; André N; David T; Girard N; Audic F; Denis D J Fr Ophtalmol; 2022 Feb; 45(2):173-184. PubMed ID: 34972579 [TBL] [Abstract][Full Text] [Related]
30. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. King A; Listernick R; Charrow J; Piersall L; Gutmann DH Am J Med Genet A; 2003 Oct; 122A(2):95-9. PubMed ID: 12955759 [TBL] [Abstract][Full Text] [Related]
31. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1. Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370 [TBL] [Abstract][Full Text] [Related]
32. Optic pathway glioma and endocrine disorders in patients with and without NF1. Gil Margolis M; Yackobovitz-Gavan M; Toledano H; Tenenbaum A; Cohen R; Phillip M; Shalitin S Pediatr Res; 2023 Jan; 93(1):233-241. PubMed ID: 35538247 [TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma. Eid H; Crevier-Sorbo G; Aldraihem A; Menegotto F; Wilson N AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560 [TBL] [Abstract][Full Text] [Related]
34. Isolated Optic Nerve Glioma in Children With and Without Neurofibromatosis: Retrospective Characterization and Analysis of Outcomes. Hamideh D; Hoehn ME; Harreld JH; Klimo PD; Gajjar A; Qaddoumi I J Child Neurol; 2018 May; 33(6):375-382. PubMed ID: 29502465 [TBL] [Abstract][Full Text] [Related]
36. Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series. Sahinoglu-Keskek N; Altan-Yaycioglu R; Canan H; Coban-Karatas M; Erbay A; Yazıcı N; Alkan O Curr Eye Res; 2018 Mar; 43(3):424-427. PubMed ID: 29185816 [TBL] [Abstract][Full Text] [Related]
38. Macrocephaly Is Not a Predictor of Optic Pathway Glioma Development or Treatment in Neurofibromatosis Type 1. Morris SM; Monroe CL; Gutmann DH J Child Neurol; 2016 Dec; 31(14):1540-1545. PubMed ID: 27581847 [TBL] [Abstract][Full Text] [Related]
39. High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report. Mikirova N; Hunnunghake R; Scimeca RC; Chinshaw C; Ali F; Brannon C; Riordan N Am J Case Rep; 2016 Oct; 17():774-781. PubMed ID: 27773919 [TBL] [Abstract][Full Text] [Related]
40. Optic pathway gliomas in children with and without neurofibromatosis 1. Czyzyk E; Jóźwiak S; Roszkowski M; Schwartz RA J Child Neurol; 2003 Jul; 18(7):471-8. PubMed ID: 12940652 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]